Sun Pharma recalls 200 vials of chemotherapy drug: Report

03 Jul 2014 Evaluate

Sun Pharmaceutical Industries, reportedly, is recalling 200 vials of the chemotherapy drug gemcitabine in the United States (US) due to a lack of assurance of sterility. The drug being recalled was manufactured by Sun Pharma's unit Caraco Pharmaceutical Laboratories at its plant in Gujarat.

Meanwhile, the voluntary recall was initiated in April and was classified by the FDA as Class II, implying that use of or exposure to the recalled drug may cause temporary or medically reversible adverse health consequences.

Lastly, this marks Sun Pharma's second drug recall this year. In January, the company started a voluntary recall of about 2,528 bottles of its generic version of diabetes drug Glumetza, after it received a customer complaint that one of the bottles contained tablets of an epilepsy drug.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1532.85 0.00 (0.00%)
18-May-2024 12:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.85
Dr. Reddys Lab 5812.50
Cipla 1403.90
Zydus Lifesciences 1104.45
Lupin 1661.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.